LADENBURG THALMANN FINANCIAL SERVICES INC. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 83 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q4 2019$4,000
+33.3%
1380.0%0.00%
Q3 2019$3,000
+50.0%
1380.0%0.00%
Q2 2019$2,000
-33.3%
1380.0%0.00%
Q1 2019$3,0000.0%138
+17.9%
0.00%
Q4 2018$3,000
+200.0%
117
+588.2%
0.00%
Q3 2018$1,000170.0%0.00%
Q2 2018$0170.0%0.00%
Q1 2018$0170.0%0.00%
Q4 2017$0
-100.0%
170.0%0.00%
Q3 2017$1,0000.0%170.0%0.00%
Q2 2017$1,0000.0%170.0%0.00%
Q1 2017$1,0000.0%170.0%0.00%
Q4 2016$1,0000.0%170.0%0.00%
Q3 2016$1,000170.0%0.00%
Q2 2016$0170.0%0.00%
Q1 2016$0170.0%0.00%
Q4 2015$0170.0%0.00%
Q3 2015$017
-34.6%
0.00%
Q2 2015$0260.0%0.00%
Q1 2015$026
+52.9%
0.00%
Q4 2014$0170.0%0.00%
Q3 2014$0170.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2015
NameSharesValueWeighting ↓
Woodford Investment Management Ltd 11,213,879$254,331,00030.84%
Cormorant Asset Management, LP 1,300,000$29,484,0002.18%
Baupost Group 9,309,168$211,132,0001.85%
SENZAR ASSET MANAGEMENT, LLC 27,397$621,0001.79%
ARMISTICE CAPITAL, LLC 1,180,000$26,762,0001.75%
Old West Investment Management, LLC 111,101$2,519,0001.27%
Chescapmanager LLC 403,321$9,147,0001.06%
Virtus ETF Advisers LLC 30,055$682,0000.60%
Rock Springs Capital Management LP 652,600$14,801,0000.57%
Foundation Asset Management, LP 27,154$616,0000.53%
View complete list of THERAVANCE BIOPHARMA INC shareholders